The Scientist - Home

A pill is shown on a blue technical background. One half of the pill has a DNA helix on it, and the other half has a depiction of a computer chip, representing the role of artificial intelligence in drug development.
| 3 min read
2026 will be the year that artificial intelligence accelerates multiple aspects of the drug discovery and development pipeline, industry leaders predict.

Latest

An image of lung tissue acquired using a MALDI imaging mass spectrometer.

Glycogen Metabolism May Play a Key Role in Pulmonary Fibrosis

Melanocyte stem cells are shown in red and other cell nuclei are shown in blue.

Hair Turns Gray Due to Stuck Stem Cells

Illustration showing origami tardigrade, fungi and bacteria.

Magnifying Curiosity with a Pocket Microscope

An elderly person in beige shirt and a knitted, cream-colored vest holds a wooden walking stick.

New Epigenetic Clocks May Confirm Extreme Age

The image shows two adult prairie voles. The voles have a brown coat and are touching each other’s snouts.

Molecular Signatures of a Broken Heart

Matthew Disney

A Quest to Drug RNA

The image shows six different panels containing cells. On each panel, the cells are labelled using a different fluorescent dye that highlights features of a specific organelle within the cells.

Cell Painting: Exploring the Richness of Biological Images

3D multicolored conceptual image representing hallucinogens and the human brain.

Natural High: Endogenous Psychedelics in the Gut and Brain

Image of someone scratching their skin.

A Chronic Itch: Burrowing Beneath the Skin

Illustration of talking AI

What Can ChatGPT-like Language Models Tell Us About the Brain?

A man sitting at a desk in a white lab coat holds up a large model of a <em >Drosophila</em> fly. In the background is a window and a bookcase.

The Origins and Recent Promise of Nonsense Suppressor tRNAs

This shows a cryo-EM map of a Fanzor protein in complex with its guiding RNA (in purple) and DNA (target strand in red, complementary strand in blue).

CRISPR-like Abilities in Eukaryotic Proteins

Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies